HERO, Version 2.0
by Medical Predictive Science Corp.
510(k) K081473
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK081473 | Date27 Jun 2008 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DPS
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2340
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The HERO, Version 2.0 is a Cardiac Monitoring Device designed to acquire, store, analyze, and report electrocardiogram (ECG) data from infants. It functions as a diagnostic tool to continuously monitor heart rhythms in neonatal or pediatric intensive care settings, providing real-time cardiac assessment under direct healthcare supervision. This device supports early detection of arrhythmias or other cardiac abnormalities in high-risk infants.
The HERO, Version 2.0 is intended for use exclusively in hospital-based neonatal or pediatric intensive care units (ICUs) under the direct supervision of a licensed healthcare practitioner. It is supplied as a reusable medical device, with no specified sterility requirements beyond standard hospital disinfection protocols. The device complies with FDA 510(k) clearance (K081473) under the Cardiovascular advisory committee, classified under product code DPS. No MRI safety or single-use specifications are noted in the regulatory submission.